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Abstract
Background: Patients with Chronic Tension Type Headache (CTTH) report functional and
emotional impairments (loss of workdays, sleep disturbances, emotional well-being) and are at risk
for overuse of medication. Manual therapy may improve symptoms through mobilisation of the
spine, correction of posture, and training of cervical muscles.
We present the design of a randomised clinical trial (RCT) evaluating the effectiveness of manual
therapy (MT) compared to usual care by the general practitioner (GP) in patients with CTTH.
Methods and design: Patients are eligible for participation if they present in general practice with
CTTH according to the classification of the International Headache Society (IHS).
Participants are randomised to either usual GP care according to the national Dutch general
practice guidelines for headache, or manual therapy, consisting of mobilisations (high- and low
velocity techniques), exercise therapy for the cervical and thoracic spine and postural correction.
The primary outcome measures are the number of headache days and use of medication.
Secondary outcome measures are severity of headache, functional status, sickness absence, use of
other healthcare resources, active cervical range of motion, algometry, endurance of the
neckflexor muscles and head posture. Follow-up assessments are conducted after 8 and 26 weeks.
Discussion: This is a pragmatic trial in which interventions are offered as they are carried out in
everyday practice. This increases generalisability of results, but blinding of patients, GPs and
therapists is not possible.
The results of this trial will contribute to clinical decision making of the GP regarding referral to 
manual therapy in patients with chronic tension headache.
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The 1-year prevalence of Chronic Tension-Type Headache
(CTTH) is about 2–5% in the general population. In half
of the CTTH cases, headache-related impairment in work
performance is reported. [1,2] In addition to considerable
impact on daily functioning and work participation,
CTTH is a risk factor for overuse of analgesic medication
[3]. Only about 20% of the CTTH patients seek medical
care for their headache. This low consultation rate may be
explained by insufficient information on the effectiveness
of treatments or by previous negative health care experi-
ences.[1,4]
In primary care treatment for patients with CTTH is often
provided by the general practitioner (GP). The Dutch
national general practice guideline for the management of
headache describes diagnostic and therapeutic algo-
rithms, consisting mainly of reassurance, lifestyle advice
and medication.[5] The effectiveness of this guideline for
patients with CTTH has not been investigated.
The pathogenesis of CTTH remains unclear. Pathophysio-
logical theories considering central and peripheral pain
mechanisms are described and have been discussed in the
literature. [6] In recent research a correlation between
CTTH and impairment of the cranio-cervical musculoskel-
etal function (forward head position, trigger points trape-
zius muscle, neck mobility) has been demonstrated [7-10]
In combination with results obtained in previous studies
the present data support the hypothesis that improvement
of the cranio-cervical musculoskeletal function by a man-
ual therapy intervention (postural correction, mobilisa-
tion cervical spine, and training of cervical muscles) may
be an important factor to modify central or peripheral
pain mechanism in CTTH. [11-15]
Three randomized clinical trials have investigated the
effectiveness of manual therapy in patients with CTTH
and reported benificial effects.[16-18]. However, because
of variation in inclusion criteria, treatment techniques
(high-, low velocity mobilization, exercises, traction), and
small sample sizes there is insufficient evidence to support
the use of manual therapy in the treatment of CTTH. Well-
designed clinical trials are recommended to provide more
substantial evidence for the effectiveness of manual ther-
apy. [19,20]
Design
We aim to conduct a pragmatic, multicentre, randomised
clinical trial, assessing the effectiveness of manual therapy
(MT) compared to usual GP care in patients with CTTH.
We have used the guidelines of the International Head-
ache Society (IHS) for the design of randomised clinical
trials for headache to develop the randomisation proce-
dure, outcome measurements and statistical analysis.[21]
The procedures and design of this study are approved by
the Medical Ethics Committee of the VU University Med-
ical Center in Amsterdam, The Netherlands. (Trial regis-
tration number TR 1074)
Study population
Participating primary healthcare centers and GPs in an
urban area in the Netherlands, will invite patients with
headache to participate in the trial.
Patients between 18 and 65 years of age are invited if they
have CTTH according to the classification of headaches of
the IHS [22]: headache occuring on at least 15 days on
average per month for a period of more than 3 months (≥
180 days a year) and lasts for hours or may be continuous.
The headache has at least one of the following character-
istics: 1. bilateral location, 2. pressing/tightening (non
pulsating) quality, 3. mild or moderate intensity, not
aggravated by normal physical activities such as walking
or climbing stairs; and both of the following: 1. no more
than one of photofobia, phonophobia or mild nausea,
and 2. neither moderate or severe nausea nor vomiting.
Participants should be able to read and write Dutch.
Exclusion criteria include reumatoid arthritis, suspected
malignancy, pregnancy, intake of either triptans, ergot-
amines or opioids on ≥ 10 days/month or simple analge-
sics on ≥ 15 days/month on a regular basis for ≥ 3 months,
and having received manual therapy treatment in the 2
months before enrolment into the study.
After the GP has seen a patient with CTTH the patient
receives an information letter about the trial. If the patient
is willing to participate after reading the information he or
she can contact the research centre. A researcher will
screen interested patients by telephone and make an
appointment to check inclusion and exclusion criteria,
and complete the informed consent procedure. After writ-
ten informed consent has been obtained, the baseline
measurement is carried out. The design of the trial is
explained in Figure 1.
Baseline assessment
Table 1 shows the outcome measures and the time points
at which they are assessed. At baseline we will collect addi-
tional information on demographic variables including
age, gender, date of birth, education and occupation. The
patient will also be asked to score expectations regarding
the effectiveness of treatment on a 7-point rating scale (no
result at all to very good result). In a standardised history
taking procedure including the two-week headache-diary,
the diagnosis of CTTH according to the diagnostic criteria
of the IHS guideline will be confirmed.[22]
Randomisation
Randomisation will take place after baseline measure-
ment by the research assistant. Before the start of the trialPage 2 of 7
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generated random numbers. Allocation is carried out by
the research assistant who has not been informed about
the random sequence, by giving the patient a numbered
and sealed envelope.
The patient will open the envelope in the presence of
another independent administrative assistant, who will
subsequently make an appointment for the first treatment
session either by the patient's own GP, or by one of the
participating manual therapists.
Blinding
GPs and manual therapists cannot be blinded for treat-
ment allocation, but will not be informed about the
results of outcome measurements. The research assistant
is kept blind for the patient's treatment allocation.
Data collection and administration will by carried out by
an independent data assistent. The researcher is involved
in the statistical analysis, but the analysis and interpreta-
tion of the findings will be audited and verified by an
independent statistician.
GP intervention
Patients will be treated by the GP according to the
national clinical guideline for the management of head-
ache [5]. According to this guideline the GP will provide
information, reassurance and advice and will discuss the
benefits of lifestyle changes. If necessary, GPs may pre-
scribe analgesics or non- steroid anti-inflammatory drugs
(NSAID) or change current pain medication.
Manual Therapy intervention
MT treatment will include a combination of mobilisation
of the cervical and thoracic spine, exercises and postural
correction based on the management of cervicogenic
headache. [23] Spinal mobilisations will consist of low
and/or high-velocity cervical and thoracic joint mobiliza-
tion and manipulation techniques. Therapeutic exercises
consist of low-load craniocervical muscle endurance exer-
cises and correction of sitting and standing posture. The
participating MT's are registrated MT's and member of the
national association of manual therapists. They have an
average experience of 10 years as manual therapist and
have completed the McKenzie B-course on the cervical
spine. In two meetings the MTs have been trained in the
treatment protocol, they have received a manual and
patient-booklets with home exercises.
Depending on the patient's condition the MT can decide
what type of techniques and exercises will be selected
from the protocol. The MT will make a report of the treat-
ment modalities used in each session.
The MT intervention is restricted to a maximum of 9 ses-
sions (each 30 minutes) in 8 weeks after randomisation.
Primary outcome measures
The follow-up measurements will take place by a blinded
research assistant immediately after the 8 weeks treatment
period and after 26 weeks (long term follow-up). Two
weeks before each measurement the patients receive and
complete a two-week headache diary. The primary out-
come measures are 1) the frequency of days with head-
ache, and 2) use of pain medication (no. of doses NSAIDs
or simple analgesics). Registration over a two week period
is considered to be sufficient.[24]
Secondary outcome measures
The secondary outcome measures include:
* Headache pain intensity measured on a 10 point numer-
ical rating scale (0 = no pain, 10 = most severe pain).
* The impact of headache on daily life will be scored by
the patient using the Headache Disability Inventory
Flow chart, representing the design of the trial on Chronic Tension Type H adache (CTTH)igure 1
Flow chart, representing the design of the trial on 
Chronic Tension Type Headache (CTTH).
Patients with CTTH are identified by 
GPs
  Screening of eligible patients 
              by telephone 
Research clinic: 
- Check in- and exclusion criteria 
- Informed consent 
- Baseline assessment
Randomisation 
           
Usual care by GP: 
- advice & education 
- pain medication  
  (if needed)
Manual therapy: 
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- postural correction 
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includes 25 questions on physical and emotional func-
tioning with three possible response options: no = 0
points, sometimes = 2 points, yes = 4 points. A total score
is computed by summating all scores, resulting in an indi-
vidual HDI score ranging from 0 (no disability) to 100
(severe disability). A decrease in the total HDI of ≥ 16
points is considered to be a significant improvement. The
test-retest reliability of the total score has been shown to
be adequate (Pearson r 0.76 for 1 week; r = 0.83 for 6
weeks) [25]
* The Headache Impact Test (HIT-6) consists of 6 items
(pain intensity, social functioning, role functioning, vital-
ity, cognitive functioning and psychological distress) each
with 5 response options; never: 6 points, rarely: 8 points,
sometimes: 10 points, very often: 11 points, always: 13
points, with a total score ranging from 36 to 78 points.
Internal consistency (Cronbach alpha: 0.89) and test-
retest reliability (ICC ranging from 0.78 to 0.90) have
been demonstrated to be good.[26] The HIT-6 is able to
differentiate between mild, moderate and severe head-
ache. A between-group difference in HIT 6 change score of
2.3 points over time among patients with chronic daily
headache reflects improvement in headache that may be
considered to be clinically significant. [27]
* The active range of movement in flexion, extension,
right and left rotation and right and left lateroflexion of
the cervical spine with the patient in a seated position will
be measured by the research assistant with the CROM-
device. The intra- and intertester reliability have been
shown to be good (ICC. > 0.80). [28]
* Algometry on the trapezius descendens and the suboc-
cipital muscle will be performed with a Wagner FDK
algometer with a 3.0 kg/cm pressure at four points at the
left and right side: two points on the upper trapezius mus-
cle and two points on the suboccipital muscle. Patients
will rate the severity of pain on a 0–10 point NRS scale (0
= no pain, 10 most severe pain). Scores for each pressure
point will be summated into a total score ranging between
0 and 80 points. Mechanical pressure algometry has been
described by several authors as a valid measurement for
pain pressure treshold for the trapezius muscle and has a
good to excellent intertester- (ICC 0.70–0.91), intratester
reliability (ICC 0.84–0.88) and a intra-individual coeffi-
cient of variation of 18.5% at 1 week test-retest. [29-31]
* Endurance of the neck flexor muscles will be scored as
the number of seconds the patient can raise his head from
the table when lying on his/her back. In a study of the
neckflexor endurance test among subjects without neck
Table 1: Summary of data collection.
Baseline After 8 weeks After 26 weeks Measurement
Sociodemographics X Single items
Treatment expectations X 7-point rating scale
Primary outcome measures
Headache frequency X X X Headache diary
Medication use X X X Headache diary
Secondary outcome measures
Headache pain intensity X X X 10 points scale
Headache Impact on daily life X X X HIT-6 HDI
Active range of movement Cervical spine X X X CROM
Algometry M. Trapezius and suboccipital muscles X X X Algometer
Craniocervical angle X X X Digital photo
Endurance neck flexor muscles X X X Neck flexor endurance test
Use of health care resources X ChecklistPage 4 of 7
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reliability (ICC 0.82–0.91) and moderate intertester relia-
bility (ICC 0.67–0.78).[32]
* A lateral digital picture with a digital HP R707.5 camera
will be taken in a seated and standing position to measure
the craniocervical angle. Recently van Niekerk et al. evalu-
ated the criterion validity of photographic measurement
compared with a digital radiographic device (LODOX) for
assessing the craniocervical angle in sitting position
among high school students (Pearson r 0.89).[33] The
reliability of photographic measurement of the craniocer-
vical angle has been reported to be good in two stud-
ies(ICC >0.86). [33,34]
* Additional use of health care resources (including GP,
psychologist, physiotherapist, acupuncture) will be
reported by the patient at 26 week follow-up by complet-
ing a checklist. The patient will also be asked to report per-
ceived improvement following treatment on a 7 point
scale. (0 = much worse to 6 = much better).
Sample size
In a pilot study the 2 weeks headache diary showed an
average of 11 days with headache in both treatment
groups at baseline. After 8 weeks the frequency of days
with headache in the GP group was reduced to 7 days, in
the MT group to 3 days. In the full trial we aim to detect a
difference in reduction of at least 3 days (SD 5) between
both groups. To detect this difference with a one-sided sig-
nificance level of 0.05, and power of 0.80 we have to
include at least 35 patients in each treatment group. The
participants in the pilot study reported taking on average
2 doses of NSAID or analgesics per 2 weeks. With a sample
size of 35 patients per group we can detect a difference of
at least 0.5 (SD 0.8) doses per 2 weeks between the
groups. With a calculated loss of participants in the full
trial of 15%, this trial attempts to enroll forty-two patients
with CTTH in each treatment groups (GP, MT).
Statistical analysis
Baseline comparability will be investigated by descriptive
statistics to examine whether randomisation was success-
ful. For each patient, the change between baseline and fol-
low-up will be calculated for all primary and secondary
outcome measures. The statistical analysis will be per-
formed according to the intention-to-treat principle.
Between group differences and 95% confidence intervals
will be calculated, and tested using the Student t-test in
case of normal distributions. Non paramaratric testing
will be used for non-normal distributions. In addition, a
per-protocol analysis will be performed, analysing only
those patients with no serious protocol deviations. Com-
paring the results of the intention-to-treat and the per-
protocol analysis will indicate if and to what extent proto-
col deviations might have influenced the results. Multivar-
iate regression analysis will be conducted to examine the
potential influence of differences in baseline characteris-
tics on outcome.
If results on primary outcomes show normal distributions
we will compute effect sizes (standardised mean differ-
ences) as the mean difference between groups over the
pooled standard deviation. Effect sizes will be rates as fol-
lows: small (0.2–0.5), medium (0.5–0.8) or large (>0.8).
Feasibility of the study design
A pilot study was conduced between June 2006 and
December 2006 to evaluate the feasibility of the measure-
ments, randomisation-procedure and treatment protocols
(33). The recruitment of participants for this pilot-study
took place in two primary health-care centers in The Neth-
erlands. A total of 20 patients were randomised to either
the GP or the MT intervention group. Thirty-one patients
who had a strong preference for the manual therapy inter-
vention and could not be randomised were asked to par-
ticipate in a parallel cohort-study. In this study similar
baseline and follow up measurements were conducted.
The results of the pilot study showed that the procedures
were feasible. The research-assistants, general practition-
ers and manual therapists reported having no problems to
adhere to the guidelines and protocols for measurements
and treatment. In order to include a total of 80 patients
over a period of one year, 32 GPs and 4 MTs have been
recruited to participate in the full trial.
Discussion
We have described the design of a RCT to evaluate the
effectiveness manual therapy compared to GP usual care
for patients with CTTH. Both approaches are commonly
used: most GPs will consult recommendations by the
national clinical guideline when managing patients with
headache. The manual therapy intervention is based on a
treatment protocol developed in consensus with the par-
ticipating MTs, and consists of commonly used mobilisa-
tion techniques and exercises. This pragmatic design will
increase the external validity of the results of this trial. The
MT treatment is assumed to improve cervical and thoracic
spine movement and function, leading to a decrease in the
frequency of headache-days. The education and exercise-
training in this program is focused on self-mangement
and postural correction, and aims for a sustained long-
term effect. Although van Ettekoven et al [34] reported
beneficial effects of a craniocervical training program for
patients with CTTH, it still remains unclear what mecha-
nisms may explain these effects. Measurement of the neck-
flexor muscle endurance, active range of motion of the
cervical spine and the craniocervical angle in our studyPage 5 of 7
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ing treatment.
This trial has a few limitations. The first limitation is the
limited possibilities for blinding. Double blinding proce-
dures in a pragmatic study cannot be obtained, and it is
not possible to blind the participating GPs, MTs and
patients for intervention. We do hope to reduce the risk of
information bias by using standardised procedures and
assessment by a blinded research assistant. The second
limitation of this pragmatic trial concerns the difference
in time spent on the patients' treatment by the GP and
MT. It is unclear to what extent this time-factor will
attribute to the overall effect of manual therapy.
Inclusion of a sufficient number of eligible patients for the
RCT will be the most difficult element of this study. Ras-
mussen et al described a low consultation rate in patients
with CTTH: only twenty percent will consult their GP [4].
The GPs will have to identify these patients during office
hours and inform them about the trial. This method of
recruitment has been reported to be associated with low
recruitment rates.[35] In order to optimize the inclusion
of patients the GPs and healthcare centers receive 'news-
letters' and visits from the researcher on a regular basis to
obtain the full participation in the trial.
The pilot study demonstrated a preference for manual
therapy in the majority of patients. For patients who do
not consent to randomisation we will conduct a parellel
cohort-study alongside the trial to monitor outcome this
group of patients. Expectations regarding the result of
treatment will be asked for all participants in both trial
and cohort, in order to estimate the potential influence of
these expectations on outcome.
To publish an article of a study design has some advan-
tages. Publication bias can be prevented whereby only
studies producing positive results are more likely to be
published.[36] It also offers an opportunity to reflect crit-
ically on the study design, independently of the results.
In this trial we will evaluate and compare two treatment
protocols (GP, MT) that reflect 'usual care' for patients
with CTTH. Therefore, the results of this pragmatic trial
will contribute to clinical decision making by the GP in
patients with CTTH, providing information on the poten-
tial benefits of a referral for manual therapy in primary
care in the Netherlands.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
RC wrote the manuscript. Critical revision of the manu-
script and contribution to the study design and statistical
analyses by DvdW, JD and BM. RC, DvdW, JD and AG par-
ticipate in the coordination of the study. All authors read
and approved the final manuscript.
References
1. Rasmussen BK: Epidemiology of headache.  Cephalalgia 2001,
21:774-777.
2. Jensen R: Diagnosis, epidemiology and impact of tension-type
headache.  Curr Pain Headache Rep 2003, 7(6):455-459.
3. Zwart AJ, Dyb G, Hagen K, Svebak S, Stovner LJ, Holmen J: Analge-
sic overuse among subjects with headache, neck, and low-
back pain.  Neurology 2004, 62:1540-1544.
4. Coeytaux R, Linville J: Chronic Daily Headache in a Primary
Care Population: Prevalence and Headache Impact Test
Scores.  Headache 2007, 47:7-12.
5. Knuistingh Neven A, Bartelink MEL, de Jngh TOH, Ongering JEP,
Oosterhuis WW, Weerd PCM van der, Pijnenburg L, Grol MH:
NHG standaard Hoofdpijn.  Huisarts en Wetenschap 2004,
46(9411-422 [http://nhg.artsennet.nl/upload/104/standaarden/M19/
start.htm].
6. Jensen R: Peripheral and central mechanisms in tension-type
headache: an update.  Cephalalgia 2003, 23(Suppl 1):49-52.
7. Fernandez-de-las-Penas C, Alonso-Blanco C, Luz Cuadrado M, Ger-
win R, Pareja J: Trigger Points in the Suboccipital Muscles and
Forward Head Posture in Tension-Type Headache.  Headache
2006, 46:454-460.
8. Fernandez-de-las-Penas C, Luz Cuadrado M, Gerwin RD, Pareja JA:
Myofascial Trigger Points and Headache Clinical Parameters
in Chronic Tension-type Headache.  Headache 2006,
46(8):1264-1272.
9. Fernandez-de-las-Penas C, Luz Cuadrado M, Arendt-Nielsen L, Hong-
You Ge, Pareja JA: Increased Pericranial Tenderness,
Decreased Pressure Pain Threshold, and Headache Clinical
Parameters in Chronic Tension-type Headache Patients.  Clin
J Pain 2007, 23:346-352.
10. Fernández-de-las-Peñas C, Alonso-Blanco C, Cuadrado ML, Pareja JA:
Forward head posture and neck mobility in chronic tension-
type headache: a blinded, controlled study.  Cephalalgia 2006,
26:314-319.
11. Watson DH, Trott PH: Cervical headache: an investigation of
natural head posture and upper cervical muscle perform-
ance.  Cephalalgia 1993, 13(4):272-284.
12. Zwart A: Neck Mobility in Different Headache Disorders.
Headache 1997, 37:6-11.
13. Ashina S, Babenko L, Jensen R, Ashina M, Magerl W, Bendtsen L:
Increased muscular and cutaneous pain sensitivity in
cephalic region in patients with chronic tension-type head-
ache.  European Journal of Neurology 2005, 12(7):543-549.
14. Marcus DA, Scharff L, Mercer S, Turk DC: Muskuloskeletal abnor-
malities in chronic headache: a controlled comparison of
headache diagnostic groups.  Headache 1999, 39:21-27.
15. Hagen K, Einarsen C, Zwart JA, Svebak S, Bovim G: The co-occur-
rence of headache and muskuloskeletal symptoms amongst
51 050 adults in Norway.  European journal of Neurology 2002,
9:527-533.
16. Demirturk F, Akarcali I, Akbayrak T, Citak I, Inan L: Results of two
different manual therapy techniques in chronic tension-type
headache.  The Pain Clinic 2002, 14(2):121-128.
17. Hoyt H, Schaffer F, Bard D, Benesler J: Osteopathic manipulation
in the treatment of muscle-contraction headache.  JAOA 1979,
78:322-325.
18. Boline PD, Kassak K, Bronfort G, Nelson C, Anderson AV: Spinal
manipulation vs. amitriptyline for the treatment of chronic
tension-type headaches: a randomized clinical trial.  J Manipu-
lative Physiol Ther 1995, 18(3):148-154.
19. Fernandez-de-las-Penas C, Alonso-Blanco C, Luz Cuadrado M, Mian-
golarra JC, Barriga FJ, Pareja JA: Are Manual Therapies Effective
in Reducing Pain From Tension-Type Headache? A System-
atic Review.  Clin J Pain 2006, 22:278-285.
20. Lenssinck M, Damen L, Verhagen AP, Berger M, Passchier J, Koes B:
The effectiveness of physiotherapy and manipulation in
patients with tension-type headache: a systematic review.
Pain 2004, 112:381-388.
21. Andrasik F, Lipchik GL, McCrory DC, Wittrock DA: Outcome
measurement in behavioral headache research: headachePage 6 of 7
(page number not for citation purposes)
BMC Musculoskeletal Disorders 2009, 10:21 http://www.biomedcentral.com/1471-2474/10/21Publish with BioMed Central   and  every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
parameters and psychosocial outcomes.  Headache 2005,
45(5):429-437.
22. The International Classification of Headache Disorders.
Cephalalgia 2nd edition. 2004, 24(Suppl 1):9-160.
23. Jull GA: Management of cervical headache.  Manual Therapy
1997, 2(4):182-190.
24. Penzien DB, Andrasik F, Freidenberg BM, Houle TT, Lake AE, Lipchik
GL, Holroyd KA, Lipton RB, McCrory DC, Nash JM, Nicholson RA,
Powers SW, Rains JC, Wittrock DA, American Headache Society
Behavioral Clinical Trials Workgroup: Guidelines for trials of
behavioral treatments for recurrent headache, first edition:
American Headache Society Behavioral Clinical Trials
Workgroup.  Headache 2005, 45(Suppl 2):S110-132.
25. Jacobson GP, Ramadan NM, Norris L, Newman CW: Headache
Disability Inventory (HDI): Short-term Test-Retest Reliabil-
ity and Spouse Perceptions.  Headache 1995, 35:534-539.
26. Kosinski M, Bayliss MS, Bjorner JB, Ware JE Jr, Garber WH, Baten-
horst A, Cady R, Dahlof CG, Dowson A, Tepper S: A six-item
short-form survey for measuring headache impact: the HIT-
6.  Qual Life Res 2003, 12(8):963-974.
27. Coeytaux R, Kaufman J, Chao R, Mann J, DeVellis R: Four methods
of estimating the minimal important differencescore were
compared to establish a clinically significant change in Head-
ache Impact Test.  Journal of Clinical Epidemiology 2006, 59:374-380.
28. Tousignant M, Smeesters C, Breton AM, Breton E, Corriveau H: Cri-
terion validity study of the cervical range of motion (CROM)
device for rotational range of motion on healthy adults.  J
Orthop Sports Phys Ther 2006, 36(4):242-248.
29. Fischer AA: Pressure algometry over normal muscles. Stand-
ard values, validity and reproducibility of pressure treshold.
Pain 1987, 30:115-126.
30. Nussbaum E, Downes L: Reliability of clinical pressure pain
algometric measurements obtained on consecutive days.
Physical Therapy 1998, 78:160-169.
31. Antonaci F, Sand T, Lucas GA: Pressure algometry in healthy
subjects: interexaminer variability.  Scand J Rehab Med 1998,
30:3-8.
32. Harris KD, Heer DM, Roy TC, et al.: Reliability of a measurement
of neck flexor muscle endurance.  Physical Therapy 2005,
85:1349-1355.
33. van Niekerk SM, Louw Q, Vaughan C, Grimmer-Somers K, Schreve
K: Photographic measurement of upper-body sitting posture
of high school students: a reliability and validity study.  BMC
Musculoskeletal Disorders 2008, 9:113.
34. Raine S, Twomey L: Head and Shoulder Posture Variations in
160 Asymptomatic Women and Men.  Arch Phys Med Rehabil
1997, 17(8):1215-1223.
35. Castien R: Pilotstudy of a randomized clinical trial: effectivi-
ness of treatment for chronic tension-type headache by the
general practitioner and manual therapist Master thesis.
2006.
36. van Ettekoven  H, Lucas C: Efficacy of physiotherapy including a
craniocervical training programme for tension-type head-
ache; a randomized clinical trial.  Cephalalgia 2006, 26:983-991.
37. Wouden JC van der, Blankenstein AH, Huibers MJ, Windt DA van
der, Stalman WA, Verhagen AP: Survey among 78 studies
showed that Lasagna's law holds in Dutch primary care
Research.  J Clin Epidemiol 2007, 60(8):819-824.
38. Eastbrook PJ, Berlin JA, Gopalan R, Matthews DR: Publication Bias
in Clinical Research.  Lancet 1991, 337:867-872.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-2474/10/21/pre
pubPage 7 of 7
(page number not for citation purposes)
